{"schema_version":"secwatch.filing_event.v1","accession":"0001125345-26-000054","form_type":"8-K","ticker":"MGNX","cik":"0001125345","company_name":"MACROGENICS INC","filed_at":"2026-08-13T20:07:52+00:00","discovered_at":"2026-08-13T20:10:02.663337+00:00","generated_at":"2026-08-13T20:10:22.701644+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"MacroGenics Q2 net income $19.5M; sells manufacturing to Bora for $122.5M, cash runway to 2028","bullets":["Q2 2026 revenue $32.8M vs $6.9M YoY; net income $19.5M vs net loss $36.3M YoY, driven by $24.5M Sanofi TZIELD milestone and $89.2M discontinued ops gain.","Completed sale of GMP manufacturing to Bora for $122.5M base price; received $119.6M cash at closing; workforce cut to ~140 employees.","Pro forma cash $327M as of June 30, 2026 (incl. Bora, Sanofi, Gilead proceeds); cash runway guided through 2028.","Gilead exercised option for preclinical bispecific program, triggering $10.0M payment; eligible for up to ~$2.4B in future milestones from partners.","Pipeline: MGC026 SCCHN cohort met threshold to advance to Stage 2; MGC030 IND cleared, first patient Q3 2026; MGC028 update late 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001125345-26-000054","json":"https://secwatch.observer/filing/0001125345-26-000054.json","markdown":"https://secwatch.observer/filing/0001125345-26-000054.md","text":"https://secwatch.observer/filing/0001125345-26-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1125345/000112534526000054/0001125345-26-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1125345/000112534526000054/mgnx-20260813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T20:10:22.701644+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}